CT-guided percutaneous marking of small pulmonary nodules with [99mTc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control.

IF 8.6 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois
{"title":"CT-guided percutaneous marking of small pulmonary nodules with [<sup>99m</sup>Tc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control.","authors":"Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois","doi":"10.1007/s00259-023-06410-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The detection of small lung nodules in thoracoscopic procedure is difficult when the lesions are not located within the outer border of the lung. In the case of ground-glass opacities, it is often impossible to palpate the lesion. Marking lung nodules using a radiotracer is a known technique. We analysed the accuracy and safety of the technique and the potential benefits of operating in a hybrid operating room.</p><p><strong>Methods: </strong>57 patients, including 33 (58%) females with a median age of 67 years (range 21-82) were included. In 27 patients, we marked and resected the lesion in a hybrid room. In 30 patients, the lesion was marked at the department of radiology the day before resection. [<sup>99m</sup>Tc]Tc-Macrosalb (Pulmocis<sup>®</sup>) was used at an activity of 1 MBq in the hybrid room and at an activity of 3 MBq the day before to get technical feasible results. Radioactivity was detected using the Neoprobe<sup>®</sup> detection system.</p><p><strong>Results: </strong>Precise detection and resection of the nodules was possible in 95% of the lesions and in 93% of the patients. Complete thoracoscopic resection was possible in 90% of the patients. Total conversion rate was 10%, but conversion due to failure of the marking of the nodule was observed in only 5% of the patients. Histology revealed 28 (37%) primary lung cancers, 24 (32%) metastases and 21 (28%) benign lesions. In 13 (23%) patients, minor complications were observed. None of them required additional interventions.</p><p><strong>Conclusion: </strong>The radio-guided detection of small pulmonary nodules is very accurate and safe after CT-guided injection of [<sup>99m</sup>Tc]Tc-Macrosalb. Performing the operation in a hybrid room has several logistic advantages and allows using lower technetium-99m activities. The technique allows minimally invasive lung sparing resection and prevents overtreatment of benign and metastatic lesions.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":null,"pages":null},"PeriodicalIF":8.6000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11300552/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-023-06410-1","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/31 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The detection of small lung nodules in thoracoscopic procedure is difficult when the lesions are not located within the outer border of the lung. In the case of ground-glass opacities, it is often impossible to palpate the lesion. Marking lung nodules using a radiotracer is a known technique. We analysed the accuracy and safety of the technique and the potential benefits of operating in a hybrid operating room.

Methods: 57 patients, including 33 (58%) females with a median age of 67 years (range 21-82) were included. In 27 patients, we marked and resected the lesion in a hybrid room. In 30 patients, the lesion was marked at the department of radiology the day before resection. [99mTc]Tc-Macrosalb (Pulmocis®) was used at an activity of 1 MBq in the hybrid room and at an activity of 3 MBq the day before to get technical feasible results. Radioactivity was detected using the Neoprobe® detection system.

Results: Precise detection and resection of the nodules was possible in 95% of the lesions and in 93% of the patients. Complete thoracoscopic resection was possible in 90% of the patients. Total conversion rate was 10%, but conversion due to failure of the marking of the nodule was observed in only 5% of the patients. Histology revealed 28 (37%) primary lung cancers, 24 (32%) metastases and 21 (28%) benign lesions. In 13 (23%) patients, minor complications were observed. None of them required additional interventions.

Conclusion: The radio-guided detection of small pulmonary nodules is very accurate and safe after CT-guided injection of [99mTc]Tc-Macrosalb. Performing the operation in a hybrid room has several logistic advantages and allows using lower technetium-99m activities. The technique allows minimally invasive lung sparing resection and prevents overtreatment of benign and metastatic lesions.

用[99m锝]锝-Macrosalb在CT引导下经皮标记肺小结节非常准确,可进行微创保肺切除术:单中心质量控制。
目的:在胸腔镜手术中,如果病灶不在肺部外缘,则很难发现肺部小结节。如果是磨玻璃不透光,则往往无法触诊病灶。使用放射性示踪剂标记肺结节是一种已知的技术。我们分析了该技术的准确性和安全性,以及在混合手术室进行手术的潜在益处。方法:共纳入 57 例患者,其中女性 33 例(58%),中位年龄 67 岁(21-82 岁)。在 27 例患者中,我们在混合手术室标记并切除了病灶。30例患者在切除前一天在放射科标记病灶。在混合室中使用的[99m锝]锝-Macrosalb(Pulmocis®)的放射性活度为1 MBq,而在前一天使用的放射性活度为3 MBq,以获得技术上可行的结果。使用 Neoprobe® 检测系统检测放射性:结果:95% 的病灶和 93% 的患者都能精确检测并切除结节。90%的患者可以通过胸腔镜进行完全切除。总转归率为 10%,但只有 5%的患者因结节标记失败而转归。组织学检查结果显示,有 28 例(37%)原发性肺癌、24 例(32%)转移瘤和 21 例(28%)良性病变。13名(23%)患者出现了轻微并发症,其中没有人需要进行额外干预。结论:结论:在 CT 引导下注射 [99mTc]Tc-Macrosalb 后,放射性引导检测肺部小结节是非常准确和安全的。在混合室中进行手术具有多项后勤优势,而且可以使用较低的锝-99m活度。该技术允许进行微创肺切除术,并可避免过度治疗良性和转移性病灶。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
9.90%
发文量
392
审稿时长
3 months
期刊介绍: The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信